How Devices and Services can be part of a Product’s Life Cycle Management

14:30 - 15:05

  • Device partners can add real value to Life Cycle Management to satisfy unmet patients’ needs.
  • Pharma services can accelerate and de-risk drug product development times. Innovative device development can create differentiation and improve patient outcomes.

Guillaume Brouet, Vice-President - Analytical, Regulatory and Scientific Affairs, Aptar Pharma